Ropinirole Tablets Recalled by Accord Healthcare Following FDA Inspection
Accord Healthcare is recalling 25,344 bottles of Ropinirole 2 mg tablets due to manufacturing deviations discovered during an FDA inspection. The recall affects medications distributed in the United States, Puerto Rico, and Canada.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II precautionary recall due to manufacturing deviations with no reported illnesses or injuries. Per the rubric, theoretical hazards without reported harm score at most 3; this precautionary manufacturing recall falls within the Moderate category.
Plain-English summary
Accord Healthcare, Inc. is recalling 25,344 bottles of Ropinirole Tablets USP 2 mg due to Current Good Manufacturing Practice (CGMP) deviations discovered during an FDA inspection. The medication was manufactured by Intas Pharmaceuticals Limited and distributed in the United States, Puerto Rico, and Canada.
The affected product carries NDC number 16729-235-01 and includes the following batches: P2106370 and P2106369 (expiration date 9/30/2023), and batch P2201254 (expiration date 2/29/2024). Consumers should verify their medication against these batch numbers and expiration dates.
Patients currently taking Ropinirole should contact their healthcare provider or pharmacist to determine whether their medication is affected by this recall and to discuss next steps. The FDA has classified this as a Class II recall.
The recalled product
- Product
- ROPINIROLE (ROPINIROLE)
- Brand
- ROPINIROLE
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Batches: P2106370
- P2106369
- Exp. Date 9/30/2023
- P2201254
- Exp. Date 2/29/2024
UPCs (1)
- 316729235013
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · ROPINIROLE
- HighFDA Recalls Ropinirole 3mg Tablets due to CGMP Deviations
FDA (Drugs) · 2023-03-08
- ModerateRopinirole Tablets Recalled Due to Manufacturing Quality Violations
FDA (Drugs) · 2023-03-08
- HighRopinirole tablets recalled due to manufacturing practice deviations
FDA (Drugs) · 2023-03-08
- HighRopinirole tablets recalled due to FDA manufacturing compliance deviations
FDA (Drugs) · 2023-03-08
- ModerateRopinirole Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27